U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
TEPROTUMUMAB
Y64GQ0KC0A
US Approved Rx (2020)
First approved in 2020
General
Names
19
Classification
3
Identifiers
16
Subunits
4
Related Substances
1
TEPROTUMUMAB
Y64GQ0KC0A
US Approved Rx (2020)
First approved in 2020
General
Approval Year
2020
742
Names
19
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
TEPROTUMUMAB
Official Name
English
RG-1507
Code
English
Teprotumumab [WHO-DD]
Common Name
English
teprotumumab [INN]
Common Name
English
HZN-001
Code
English
Showing 1 to 5 of 19 entries
Previous
1
2
3
4
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Antineoplastic Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antineoplastic Biological Agent
[C129821]
Antineoplastic Antibody
NCI_THESAURUS
C129822
Designated/Approved
ORPHAN DRUG
Designated/Approved
Treatment of active thyroid eye disease
FDA ORPHAN DRUG
387812
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
16
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
RXCUI
2274803
PRIMARY
MERCK INDEX
m12242
PRIMARY
CAS
1036734-93-6
PRIMARY
FDA UNII
Y64GQ0KC0A
PRIMARY
WIKIPEDIA
TEPROTUMUMAB
PRIMARY
Showing 1 to 5 of 16 entries
Previous
1
2
3
4
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
Y64GQ0KC0A
TEPROTUMUMAB
